Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
Cecilia Söderberg-NauclerPublished in: Immunity & ageing : I & A (2021)
The majority of people infected with SARS-CoV-2 are asymptomatic or have mild to moderate symptoms. However, for unknown reasons, about 15 % have severe pneumonia requiring hospital care and oxygen support, and about 5 % develop acute respiratory distress syndrome, septic shock, and multiorgan failure that result in a high mortality rate. The risk of severe COVID-19 is highest among those who are over 70 years of age. Why severe COVID-19 develops in some people but not others is not understood. Could some cases involve reactivation of latent cytomegalovirus (CMV)?
Keyphrases
- sars cov
- coronavirus disease
- acute respiratory distress syndrome
- early onset
- septic shock
- respiratory syndrome coronavirus
- healthcare
- extracorporeal membrane oxygenation
- mechanical ventilation
- drug induced
- type diabetes
- cardiovascular disease
- cardiovascular events
- emergency department
- coronary artery disease
- intensive care unit
- depressive symptoms
- physical activity
- health insurance
- pain management
- adverse drug
- affordable care act